Skip to main content
ABION Inc. logo

ABION Inc. — Investor Relations & Filings

Ticker · 203400 ISIN · KR7203400007 KO Professional, scientific and technical activities
Open in API
Filings indexed 409 across all filing types
Latest filing 2021-09-17 Director's Dealing
Country KR South Korea
Listing KO 203400

About ABION Inc.

https://abionbio.com/en/

ABION Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative medicines, focusing on first-in-class and best-in-class therapeutics for oncology and viral diseases. The company's lead oncology asset is ABN401, a selective c-Met tyrosine kinase inhibitor (TKI) designed to treat non-small cell lung cancer (NSCLC) with MET mutations, which has shown a favorable safety profile. Another key pipeline candidate is ABN501, a novel monoclonal antibody targeting Claudin-3 for various cancers. Beyond oncology, ABION is developing ABN101, a second-generation Interferon-β formulated as a broad-spectrum anti-viral inhaler for respiratory infections. The company aims to commercialize its assets in global markets through internationally recognized clinical processes.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their personal share transactions or changes in ownership. According to the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2021-09-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (DART). This document details the personal share transactions and ownership status of a company executive (Kang Yoon Soo of Abion Co., Ltd.). According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing'.
2021-09-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure required by the Financial Supervisory Service (FSS) in South Korea when company insiders (executives or major shareholders) trade company stock. This falls under the category of Director's Dealing (DIRS), which covers personal share transactions by company directors and executives.
2021-09-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a standard Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This document is a mandatory disclosure filed with the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) when an executive or major shareholder changes their shareholding position (in this case, due to the exercise of stock options). This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions by company executives.
2021-09-16 Korean
전환청구권행사(제2회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification of the exercise of conversion rights (전환청구권행사) regarding convertible bonds (CB). This involves the issuance of new shares resulting from the conversion of debt into equity, which falls under capital structure changes. According to the provided categories, 'SHA' (Share Issue/Capital Change) is the most appropriate classification for announcements regarding new share issues or capital changes resulting from debt conversion.
2021-09-15 Korean
기타경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding the conversion of convertible preferred shares into common shares. This involves a change in the company's capital structure and share issuance. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for announcements regarding new share issues or capital changes resulting from conversions.
2021-09-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.